Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre
Open Access
- 17 December 2015
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 114 (1) , 103-109
Abstract
In contrast to the consistent evidence for obesity and colorectal cancer (CRC) risk, the impact of obesity in CRC patients is less clear. In a well-characterised cohort of CRC patients, we prospectively evaluated class I and class II obesity with survival outcomes. The CRC patients (N=634) were followed from the date of diagnosis until disease progression/first recurrence (progression-free survival (PFS)) or death (overall survival (OS)). Body mass index (BMI) was calculated from reported usual weight prior to diagnosis. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in models adjusted for clinicopathologic, treatment, and lifestyle factors. Over a median follow-up of 4 years, 208 (33%) patients died and 235 (37%) recurred or progressed. Class II obesity, as compared with either overweight or normal weight, was associated with an increased risk of death (HR and 95% CI: 1.55 (0.97–2.48) and 1.65 (1.02–2.68), respectively), but no clear association was observed with PFS. In analyses restricted to patients who presented as stages I–III, who reported stable weight, or who were aged <50 years, obesity was associated with a significant two- to five-fold increased risk of death. In CRC patients evaluated at a large cancer centre, severely obese patients experienced worse survival outcomes independent of many other factors.Keywords
This publication has 40 references indexed in Scilit:
- Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective StudiesPLOS Medicine, 2014
- Cancer Prognosis: Role of BMI and Fat TissueJNCI: Journal of the National Cancer Institute, 2014
- Prevalence of Childhood and Adult Obesity in the United States, 2011-2012JAMA, 2014
- Excess adiposity and survival in patients with colorectal cancer: a systematic reviewObesity Reviews, 2014
- Prediagnostic Body Mass Index and Pancreatic Cancer SurvivalJournal of Clinical Oncology, 2013
- Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisBreast Cancer Research, 2013
- Lifestyle factors associated with survival after colorectal cancer diagnosisBritish Journal of Cancer, 2013
- Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapyCancer, 2013
- Morbid obesity rates continue to rise rapidly in the United StatesInternational Journal of Obesity, 2012
- Effect of physical activity and body size on survival after diagnosis with colorectal cancerGut, 2006